PubMed Health⌕ Search

Biomedical subjects

P Hoch

Publications and source records attributed to P Hoch.

6 recordsLinked to original sources

Transurethral ultrasound-guided laser-induced prostatectomy: clinical outcome and data analysis.

OBJECTIVES: To analyze efficacy and side effects of the transurethral ultrasound-guided laser-induced prostatectomy (TULIP) procedure for the treatment of bladder outlet obstruction due to benign prostatic hyperplasia (BPH). Based on the results obtained so far, the influence of preoperative and intraoperative parameters on clinical outcome is analyzed. METHODS: Between May 1991 and March 1994, 89 men with symptomatic and obstructive BPH underwent a TULIP procedure and were followed after 3 and 6 weeks, and 3, 6, and 12 months postoperatively. RESULTS: On average, mean urinary peak flow increased from 7 to 15 mL/s, postvoidal residual urine decreased from 215 to 40 mL and symptoms (assessed by modified Boyarsky score) decreased from 17 to 5 at 12 months after TULIP: In about half of the patients peak flow increased to more than 20 mL/s on average, and approximately 85% of all men reported that their symptoms improved on average 80% during this time. Because of insufficient micturition, 7 patients subsequently underwent conventional transurethral resection of the prostate (TURP) and 1 had an open prostatectomy. Either partial or complete retrograde ejaculation was reported by 13 of 58 sexually active men. No blood transfusion was required and no post-transurethral resection syndrome occurred in any case. Analyses of preoperative and intraoperative parameters and clinical outcome with respect to prostate volume, urinary retention, type of BPH enlargement, sleeve size, and good and poor responders did not reveal any significant influence of any factor. There is, however, a trend toward a lower laser energy delivered in patients who failed or may be considered to be poor responders. CONCLUSIONS: In this unselected group of patients with BPH, who otherwise would have been TURP candidates, the TULIP procedure demonstrated the efficacy of this technique to relieve bladder outlet obstruction. Compared with TURP, the TULIP procedure proved to be advantageous in regard to less blood loss and rate of retrograde ejaculation. In addition, TULIP can be performed under analgesic sedation, which is especially advantageous in high-risk patients. Disadvantages, however, are that it takes a considerably longer time to obtain substantial improvements in subjective and objective symptoms and there are more irritative symptoms in the early postoperative phase.

Aged↗

[TULIP (transurethral ultrasound-controlled laser-induced prostatectomy)--experiences with over 80 patients].

Of the many methods currently under investigation for the treatment of symptomatic and obstructive benign prostatic hyperplasia (BPH), laser treatment seems the most likely to yield results comparable to those achieved with transurethral resection of the prostate (TURP). Between May 1991 and December 1993 a total of 83 men were treated in our department with the TULIP (transurethral ultrasound-guided laser-induced prostatectomy) device. Within the first year of follow-up there was a marked improvement in both signs and symptoms. The average urinary peak flow increased from 6 to 16 ml/s, the residual urine volume decreased from 218 ml to 36 ml, and the symptom score (assessed against a modified Boyarsky score) decreased from 17 to 4 points. Our experience so far indicates that the advantages of TULIP are minimal blood loss, no post-transurethral resection syndrome, and a low rate of retrograde ejaculation postoperatively. In addition, the procedure can be performed with analgosedation. Disadvantages are the delayed onset of improvement, combined with irritative symptoms in the early weeks after the procedure. In addition, no tissue can be obtained for histological examination, which may be important in the long-term. Randomized prospective studies, including cost-benefit analyses, are needed to check for advantages of TULIP over TURP.

Aged↗

Side effects and changes in pulmonary function after fixed dose precurarization with alcuronium, pancuronium or vecuronium.

On hundred and sixty premedicated patients undergoing surgery were assessed for changes in pulmonary function and signs of partial neuromuscular blockade following precurarization with a fixed dose of alcuronium 2 mg, pancuronium 1 mg or vecuronium 1 mg, and the efficacy of the drugs in the prevention of suxamethonium-associated side effects was compared. In this respect, no differences were observed between the three drugs. Pretreatment with alcuronium and pancuronium was followed by small decreases in pulmonary function. Statistically significant changes were seen only when vecuronium 1 mg was used as the fixed-dose precurarization agent.

Adult↗